LSE - Delayed Quote USD
The Allstate Corporation (0HCZ.L)
202.80
-2.96
(-1.44%)
At close: May 9 at 3:47:54 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 4 | 6 |
| Avg. Estimate | 16.82B | 17.39B | 69.08B | 74.12B |
| Low Estimate | 16.82B | 17.39B | 68.35B | 71.36B |
| High Estimate | 16.82B | 17.39B | 69.5B | 77.24B |
| Year Ago Sales | 15.71B | 16.63B | 64.11B | 69.08B |
| Sales Growth (year/est) | 7.05% | 4.61% | 7.75% | 7.30% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0HCZ.L | -- | -- | -- | -- |
| S&P 500 | 13.21% | 3.09% | 8.02% | 13.76% |
Upgrades & Downgrades
| Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 5/7/2025 |
| Maintains | Morgan Stanley: Overweight to Overweight | 5/6/2025 |
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 5/6/2025 |
| Reiterates | Raymond James: Strong Buy to Strong Buy | 5/5/2025 |
| Maintains | Evercore ISI Group: Outperform to Outperform | 5/1/2025 |
| Maintains | Barclays: Underweight to Underweight | 4/11/2025 |